Alto Neuroscience Appoints Dr. Andrew Miller to Board of Directors
Alto Neuroscience announced the appointment of Andrew Miller, Ph.D. to its Board of Directors, effective May 27, 2026. Most recently, Miller was the Founder and President of R&D at Karuna Therapeutics
